These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 39088100)
1. Effects of combined intense pulsed light and cyclosporine 0.05% eyedrops in ocular surface matrix metalloproteinase-9 levels in patients with moderate-to-severe MGD. Jeon YY; Bae S; Chung HS; Kim JY; Lee H Lasers Med Sci; 2024 Aug; 39(1):203. PubMed ID: 39088100 [TBL] [Abstract][Full Text] [Related]
2. Changes in the expression of matrix metalloproteinase-9 after intense pulsed light therapy combined with meibomian gland expression in moderate and severe meibomian gland dysfunction. Lee H; Han YE; Park SY; Lee JH; Chung HS; Moon SY; Kim JY; Tchah H Cont Lens Anterior Eye; 2021 Jun; 44(3):101339. PubMed ID: 32948417 [TBL] [Abstract][Full Text] [Related]
3. Intense Pulsed Light Therapy for Patients with Meibomian Gland Dysfunction and Ocular Demodex Infestation. Cheng SN; Jiang FG; Chen H; Gao H; Huang YK Curr Med Sci; 2019 Oct; 39(5):800-809. PubMed ID: 31612399 [TBL] [Abstract][Full Text] [Related]
4. Effects of lid debris debridement combined with meibomian gland expression on the ocular surface MMP-9 levels and clinical outcomes in moderate and severe meibomian gland dysfunction. Moon SY; Han SA; Kwon HJ; Park SY; Lee JH; Chung HS; Kim JY; Tchah H; Lee H BMC Ophthalmol; 2021 Apr; 21(1):175. PubMed ID: 33845799 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of intense pulsed light of upper and lower eyelids in Meibomian gland dysfunction: A prospective multicentric study. Benitez-Del-Castillo JM; López-Pérez MD; Cano-Ortiz A; Peris-Martinez C; Pinar-Sueiro S; Gessa-Sorroche M; García-Franco-Zuñiga C; Iradier MT; Amesty MA; Burgos-Blasco B Eur J Ophthalmol; 2024 May; 34(3):700-707. PubMed ID: 37671407 [TBL] [Abstract][Full Text] [Related]
6. Effect of intense pulsed light using acne filter on eyelid margin telangiectasia in moderate-to-severe meibomian gland dysfunction. Han JY; Lee Y; Nam S; Moon SY; Lee H; Kim JY; Tchah H Lasers Med Sci; 2022 Jun; 37(4):2185-2192. PubMed ID: 35022869 [TBL] [Abstract][Full Text] [Related]
7. Meibum Expressibility Improvement as a Therapeutic Target of Intense Pulsed Light Treatment in Meibomian Gland Dysfunction and Its Association with Tear Inflammatory Cytokines. Choi M; Han SJ; Ji YW; Choi YJ; Jun I; Alotaibi MH; Ko BY; Kim EK; Kim TI; Nam SM; Seo KY Sci Rep; 2019 May; 9(1):7648. PubMed ID: 31113979 [TBL] [Abstract][Full Text] [Related]
8. Different Number of Sessions of Intense Pulsed Light and Meibomian Gland Expression Combination Therapy for Meibomian Gland Dysfunction. Lee SH; Kim M; Lee WJ; Chun YS; Kim KW Korean J Ophthalmol; 2022 Dec; 36(6):527-542. PubMed ID: 36281571 [TBL] [Abstract][Full Text] [Related]
9. Comparative Evaluation in Intense Pulsed Light Therapy Combined with or without Meibomian Gland Expression for the Treatment of Meibomian Gland Dysfunction. Chen Y; Li J; Wu Y; Lin X; Deng X; Yun-E Z Curr Eye Res; 2021 Aug; 46(8):1125-1131. PubMed ID: 33342317 [TBL] [Abstract][Full Text] [Related]
10. Intense pulsed light treatment of the upper and lower eyelids in patients with moderate-to-severe meibomian gland dysfunction. Chung HS; Han YE; Lee H; Kim JY; Tchah H Int Ophthalmol; 2023 Jan; 43(1):73-82. PubMed ID: 35794405 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic efficacy of intense pulsed light in patients with refractory meibomian gland dysfunction. Arita R; Fukuoka S; Morishige N Ocul Surf; 2019 Jan; 17(1):104-110. PubMed ID: 30445177 [TBL] [Abstract][Full Text] [Related]
12. Intense pulsed light plus meibomian gland expression versus intense pulsed light alone for meibomian gland dysfunction: A randomized crossover study. Shin KY; Lim DH; Moon CH; Kim BJ; Chung TY PLoS One; 2021; 16(3):e0246245. PubMed ID: 33662017 [TBL] [Abstract][Full Text] [Related]
13. Intense pulsed light (IPL) therapy for the treatment of meibomian gland dysfunction. Cote S; Zhang AC; Ahmadzai V; Maleken A; Li C; Oppedisano J; Nair K; Busija L; Downie LE Cochrane Database Syst Rev; 2020 Mar; 3(3):CD013559. PubMed ID: 32182637 [TBL] [Abstract][Full Text] [Related]
14. Comparison of clinical outcomes between intense pulsed light therapy using two different filters in meibomian gland dysfunction: prospective randomized study. Jang JH; Lee K; Nam SH; Kim J; Kim JY; Tchah H; Lee H Sci Rep; 2023 Apr; 13(1):6700. PubMed ID: 37095152 [TBL] [Abstract][Full Text] [Related]
15. Changes in the Meibomian Gland After Exposure to Intense Pulsed Light in Meibomian Gland Dysfunction (MGD) Patients. Yin Y; Liu N; Gong L; Song N Curr Eye Res; 2018 Mar; 43(3):308-313. PubMed ID: 29199865 [TBL] [Abstract][Full Text] [Related]
16. Investigation of Prognostic Factors for Intense Pulsed Light Treatment with a Vascular Filter in Patients with Moderate or Severe Meibomian Gland Dysfunction. Lee Y; Jang JH; Nam S; Lee K; Kim J; Kim JY; Tchah H; Lee H J Clin Med; 2022 Aug; 11(16):. PubMed ID: 36012963 [TBL] [Abstract][Full Text] [Related]
17. Intense pulsed light improves signs and symptoms of dry eye disease due to meibomian gland dysfunction: A randomized controlled study. Toyos R; Desai NR; Toyos M; Dell SJ PLoS One; 2022; 17(6):e0270268. PubMed ID: 35737696 [TBL] [Abstract][Full Text] [Related]
18. The Approach of Intense Pulsed Light Treatment in Patients with Different Severities of Meibomian Gland Dysfunction. Yin Y; Gong L; Lu Y Curr Eye Res; 2023 Mar; 48(3):231-237. PubMed ID: 36408882 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of intense pulsed light therapy on signs and symptoms of dry eye disease: A meta-analysis and systematic review. Qin G; Chen J; Li L; Zhang Q; Xu L; Yu S; He W; He X; Pazo EE Indian J Ophthalmol; 2023 Apr; 71(4):1316-1325. PubMed ID: 37026263 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of Intense Pulsed Light in Patients With Meibomian Gland Dysfunction-A Randomized, Double-Masked, Sham-Controlled Clinical Trial. Piyacomn Y; Kasetsuwan N; Reinprayoon U; Satitpitakul V; Tesapirat L Cornea; 2020 Mar; 39(3):325-332. PubMed ID: 31764289 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]